Liquid biopsy of gliomas with detection of extracellular tumor nucleic acids

Gliomas are the reason of fatal outcomes in an overwhelming number of patients with oncology diseases located in the central nervous system. The diagnostics of such neoplasms requires using stereotaxic biopsy, which cannot be performed in a certain percentage of the patients. Besides, this disease i...

Full description

Saved in:
Bibliographic Details
Main Authors: Tagir I. Rakhmatullin, Mark Jain, Larisa M. Samokhodskaya, Andrey A. Zuev
Format: Article
Language:English
Published: Eco-vector 2024-11-01
Series:Клиническая практика
Subjects:
Online Access:https://journals.eco-vector.com/clinpractice/article/viewFile/629883/pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850150735083208704
author Tagir I. Rakhmatullin
Mark Jain
Larisa M. Samokhodskaya
Andrey A. Zuev
author_facet Tagir I. Rakhmatullin
Mark Jain
Larisa M. Samokhodskaya
Andrey A. Zuev
author_sort Tagir I. Rakhmatullin
collection DOAJ
description Gliomas are the reason of fatal outcomes in an overwhelming number of patients with oncology diseases located in the central nervous system. The diagnostics of such neoplasms requires using stereotaxic biopsy, which cannot be performed in a certain percentage of the patients. Besides, this disease is characterized by high recurrence rates, despite the advances in developing resection and chemotherapy — based technologies. The early detection of oncological diseases located in the central nervous system and the differential diagnostics of tumor pseudo progression, not affecting the survival of the patient, represents a challenge for modern Medicine. Liquid biopsy is a minimally invasive diagnostic method based on the analysis of tumor derivatives (such as extracellular tumor DNA and RNA), contained within the biological fluids of the organism. For the purpose of defining the presence of the tumor component, the tests are used to detect the so-called hot-spot mutations and the patterns of epigenetic regulation, found in specific types of tumors. The technology can be used for detecting tumor recurrences and for the differential diagnostics of space-occupying mass lesions in patients, in which stereotaxic biopsy is contraindicated. The review contains a discussion on modern advances of fluid biopsy based on the analysis of the extracellular tumor DNA and RNA levels in blood plasma and in the cerebrospinal fluid of glioma patients.
format Article
id doaj-art-8b2de9cf99e04a0f822cba664b891d4a
institution OA Journals
issn 2220-3095
2618-8627
language English
publishDate 2024-11-01
publisher Eco-vector
record_format Article
series Клиническая практика
spelling doaj-art-8b2de9cf99e04a0f822cba664b891d4a2025-08-20T02:26:27ZengEco-vectorКлиническая практика2220-30952618-86272024-11-01153829510.17816/clinpract62988378445Liquid biopsy of gliomas with detection of extracellular tumor nucleic acidsTagir I. Rakhmatullin0https://orcid.org/0000-0002-4601-3478Mark Jain1https://orcid.org/0000-0002-6594-8113Larisa M. Samokhodskaya2https://orcid.org/0000-0001-6734-3989Andrey A. Zuev3https://orcid.org/0000-0003-2974-1462Lomonosov Moscow State UniversityLomonosov Moscow State UniversityLomonosov Moscow State UniversityNational Medical and Surgical Center named after N.I. PirogovGliomas are the reason of fatal outcomes in an overwhelming number of patients with oncology diseases located in the central nervous system. The diagnostics of such neoplasms requires using stereotaxic biopsy, which cannot be performed in a certain percentage of the patients. Besides, this disease is characterized by high recurrence rates, despite the advances in developing resection and chemotherapy — based technologies. The early detection of oncological diseases located in the central nervous system and the differential diagnostics of tumor pseudo progression, not affecting the survival of the patient, represents a challenge for modern Medicine. Liquid biopsy is a minimally invasive diagnostic method based on the analysis of tumor derivatives (such as extracellular tumor DNA and RNA), contained within the biological fluids of the organism. For the purpose of defining the presence of the tumor component, the tests are used to detect the so-called hot-spot mutations and the patterns of epigenetic regulation, found in specific types of tumors. The technology can be used for detecting tumor recurrences and for the differential diagnostics of space-occupying mass lesions in patients, in which stereotaxic biopsy is contraindicated. The review contains a discussion on modern advances of fluid biopsy based on the analysis of the extracellular tumor DNA and RNA levels in blood plasma and in the cerebrospinal fluid of glioma patients.https://journals.eco-vector.com/clinpractice/article/viewFile/629883/pdfcirculating tumor dnamicrornaliquid biopsygliomacentral nervous systemcentral nervous system malignanciesscreening
spellingShingle Tagir I. Rakhmatullin
Mark Jain
Larisa M. Samokhodskaya
Andrey A. Zuev
Liquid biopsy of gliomas with detection of extracellular tumor nucleic acids
Клиническая практика
circulating tumor dna
microrna
liquid biopsy
glioma
central nervous system
central nervous system malignancies
screening
title Liquid biopsy of gliomas with detection of extracellular tumor nucleic acids
title_full Liquid biopsy of gliomas with detection of extracellular tumor nucleic acids
title_fullStr Liquid biopsy of gliomas with detection of extracellular tumor nucleic acids
title_full_unstemmed Liquid biopsy of gliomas with detection of extracellular tumor nucleic acids
title_short Liquid biopsy of gliomas with detection of extracellular tumor nucleic acids
title_sort liquid biopsy of gliomas with detection of extracellular tumor nucleic acids
topic circulating tumor dna
microrna
liquid biopsy
glioma
central nervous system
central nervous system malignancies
screening
url https://journals.eco-vector.com/clinpractice/article/viewFile/629883/pdf
work_keys_str_mv AT tagirirakhmatullin liquidbiopsyofgliomaswithdetectionofextracellulartumornucleicacids
AT markjain liquidbiopsyofgliomaswithdetectionofextracellulartumornucleicacids
AT larisamsamokhodskaya liquidbiopsyofgliomaswithdetectionofextracellulartumornucleicacids
AT andreyazuev liquidbiopsyofgliomaswithdetectionofextracellulartumornucleicacids